Patents for C12N 5 - Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor (182,629)
12/2000
12/07/2000WO2000073451A1 Mammalian receptor proteins; related reagents and methods
12/07/2000WO2000073450A2 Cytoskeleton-associated proteins
12/07/2000WO2000073449A1 Dna encoding snorf33 receptor
12/07/2000WO2000073448A1 Adipocyte complement related protein homolog zacrp7
12/07/2000WO2000073445A2 Interleukin-1-receptor associated kinase-3 (irak3)
12/07/2000WO2000073444A1 Adipocyte complement related protein homolog zacrp5
12/07/2000WO2000073443A1 Lipid metabolism transcription factor
12/07/2000WO2000073440A1 Pollinosis-associated gene 787
12/07/2000WO2000073432A2 Activation of dendritic cells to enhance immunity
12/07/2000WO2000073431A2 Methods and compositions for measuring ion channel conductance
12/07/2000WO2000073424A1 A novel baculovirus/adenovirus hybrid vector for the rescue, production and titration of high-capacity adenovirus amplicon vectors
12/07/2000WO2000073423A1 Packaging cell
12/07/2000WO2000073422A1 Genetically modified plant cells and plants with an increased activity of an amylosucrase protein and a branching enzyme
12/07/2000WO2000073421A2 Methods of isolation, cryopreservation, and therapeutic use of human amniotic epithelial cells
12/07/2000WO2000073419A1 Immortalized human middle ear epithelial cell lines
12/07/2000WO2000073418A2 A method of using autologous fibroblasts to promote healing of wounds and fistulas
12/07/2000WO2000073417A1 In vitro cell culture device including cartilage and methods of using the same
12/07/2000WO2000073416A1 Antisense oligonucleotides for fertility and menstrual cycle regulation and for chemopreventive and chemotherapeutic use
12/07/2000WO2000073415A2 A method for the transfer of antigens to dendritic cells
12/07/2000WO2000073411A1 Multi- applicable cell-culture method and apparatus
12/07/2000WO2000073349A1 Dr4 antibodies and uses thereof
12/07/2000WO2000073348A2 Methods and compositions for inhibiting neoplastic cell growth
12/07/2000WO2000073344A2 Monoclonal antibodies, synthetic and biotechnological derivatives thereof acting as ngf-antagonist molecules
12/07/2000WO2000073338A1 Compositions and methods for the therapy, diagnosis and monitoring of breast cancer
12/07/2000WO2000073335A1 Cytotoxic t-cell epitopes of the papilloma virus l1-protein and use thereof in diagnosis and therapy
12/07/2000WO2000073334A2 Human sorting nexins
12/07/2000WO2000073324A2 Modulation of gene expression in gastrointestinal inflammation
12/07/2000WO2000073323A2 Adam polynucleotides and polypeptides
12/07/2000WO2000073321A1 Human tumor necrosis factor receptor tr10
12/07/2000WO2000073319A1 Method for enhanced protein stabilization and production of cell lines useful for production of such stabilized proteins
12/07/2000WO2000072895A1 Cell-coated supports
12/07/2000WO2000072887A1 A novel packaging cell line for the rescue, production and titration of high-capacity adenovirus amplicon vectors
12/07/2000WO2000072885A2 Methods of inducing regulated pancreatic hormone production in non-pancreatic islet tissues
12/07/2000WO2000072666A2 USE OF TRANSGENIC MICE LACKING JunB EXPRESSION IN THE MYELOID LINEAGE
12/07/2000WO2000050568A3 Transplantation of haematopoietic cells
12/07/2000WO2000050565A3 Compositions, kits, and methods relating to the human fez1 gene, a novel tumor suppressor gene
12/07/2000WO2000047727A3 Nucleic acid molecules encoding alternansucrase
12/07/2000WO2000046391A3 Genes displaying enhanced expression during cellular senescence and terminal cell differentiation and uses thereof
12/07/2000WO2000043519A3 Neisseria meningitidis polypeptides
12/07/2000WO2000043500A3 Immortalized cell lines and methods of making the same
12/07/2000WO2000042561A3 Oligonucleotide mediated nucleic acid recombination
12/07/2000WO2000042205A3 Herbicide target gene and methods
12/07/2000WO2000039304A9 Polynucleotides encoding antigenic hiv type c polypeptides, polypeptides and uses thereof
12/07/2000WO2000038708A9 Treatment and prevention of immune rejection reactions
12/07/2000WO2000032140A9 System and sequential culture media for in vitro fertilization
12/07/2000WO2000031247A3 Recombinant methods and materials for producing epothilone and epothilone derivatives
12/07/2000DE19925235A1 Zytotoxische T-Zellepitope des Papillomavirus L1-Proteins und ihre Verwendung in Diagnostik und Therapie Cytotoxic T cell epitopes of the papillomavirus L1 protein and its use in diagnosis and therapy
12/07/2000DE19925199A1 Zytotoxische T-Zellepitope des Papillomavirus L1-Proteins und ihre Verwendung in Diagnostik und Therapie Cytotoxic T cell epitopes of the papillomavirus L1 protein and its use in diagnosis and therapy
12/07/2000CA2725132A1 Method for separating cells using immunorosettes
12/07/2000CA2414214A1 Four-helical bundle protein zsig81
12/07/2000CA2383244A1 Protein kinases
12/07/2000CA2378737A1 Adipocyte complement related protein homolog zacrp5
12/07/2000CA2376116A1 Promotion or inhibition of angiogenesis and cardiovascularization
12/07/2000CA2375888A1 Cytotoxic t-cell epitopes of the papillomavirus l1-protein and use thereof in diagnostics and therapy
12/07/2000CA2375873A1 Methods and compositions for isolating high molecular weight dna from natural samples
12/07/2000CA2375855A1 Modulation of gene expression in gastrointestinal inflammation
12/07/2000CA2375802A1 Cytotoxic t-cell epitopes of the papilloma virus l1-protein and use thereof in diagnosis and therapy
12/07/2000CA2375349A1 A method for the transfer of antigens to dendritic cells
12/07/2000CA2375209A1 Multi-applicable cell-culture method and apparatus
12/07/2000CA2375123A1 Use of recombinant gene delivery vectors for treating or preventing lysosomal storage disorders
12/07/2000CA2375106A1 Compositions and methods for the therapeutic use of an atonal-associated sequence for deafness, osteoarthritis, and abnormal cell proliferation
12/07/2000CA2375095A1 Groel muteins with improved stability
12/07/2000CA2375050A1 T-bet compositions and methods of use thereof
12/07/2000CA2375049A1 Compositions and methods for the therapy, diagnosis and monitoring of breast cancer
12/07/2000CA2375047A1 Dna encoding snorf33 receptor
12/07/2000CA2374599A1 Dr4 antibodies and uses thereof
12/07/2000CA2374597A1 Methods and compositions for lowering the level of tumor necrosis factor (tnf) in the tnf-associated disorders
12/07/2000CA2374412A1 Secreted alpha-helical protein-31
12/07/2000CA2374391A1 Mammalian receptor proteins; related reagents and methods
12/07/2000CA2374387A1 Adipocyte complement related protein homolog zacrp7
12/07/2000CA2374376A1 Lipid metabolism transcription factor
12/07/2000CA2374222A1 Cytoskeleton-associated proteins
12/07/2000CA2373915A1 Methods and compositions for inhibiting neoplastic cell growth
12/07/2000CA2373638A1 Adam polynucleotides and polypeptides
12/07/2000CA2372246A1 Human tumor necrosis factor receptor tr10
12/07/2000CA2372243A1 Method for enhanced protein stabilization and production of cell lines useful for production of such stabilized proteins
12/07/2000CA2371995A1 Methods of inducing regulated pancreatic hormone production in non-pancreatic islet tissues
12/07/2000CA2336262A1 Sorting nexins
12/06/2000EP1057891A1 Use of the BNM3 transcriptional activator to control plant embryogenesis and regeneration processes
12/06/2000EP1057890A1 Monoclonal antibody for immunologically analyzing or concentrating endocrine disrupting substance or its degradation product and utilization of the same
12/06/2000EP1056886A1 Hla linked pre-eclampsia and miscarriage susceptibility gene
12/06/2000EP1056880A1 Methods for purified aav vector production
12/06/2000EP1056878A1 Artificial chromosome constructs containing nucleic acid sequences capable of directing the formation of a recombinant virus
12/06/2000EP1056877A1 Self-regulated apoptosis of inflammatory cells by gene therapy
12/06/2000EP1056871A1 Cprot03, a human cysteine protease
12/06/2000EP1056869A2 Cell cycle related proteins
12/06/2000EP1056868A1 Human homolog of the drosophila protein 'fused'
12/06/2000EP1056866A1 CULTIVAR SPECIFICITY GENE FROM THE RICE PATHOGEN $i(MAGNAPORTHE GRISEA), AND METHODS OF USE
12/06/2000EP1056858A1 RECOMBINANT ACTIVE HUMAN ZONA PELLUCIDA PROTEIN 3 (hZP3)
12/06/2000EP1056857A2 Transporter for saccharide-coupled medicaments
12/06/2000EP1056855A2 Exo1 and exo2, exocytotic proteins
12/06/2000EP1056854A2 Protease-activated receptor 4 and uses thereof
12/06/2000EP1056853A2 Human channel-related molecules
12/06/2000EP1056849A1 Human smn-like protein
12/06/2000EP1056848A1 Human protein kinase c inhibitor
12/06/2000EP1056847A2 HUMAN PROTEINS HAVING TRANSMEMBRANE DOMAINS AND DNAs ENCODING THESE PROTEINS
12/06/2000EP1056846A1 Cerebellin-2 related polypeptides and dna coding therefor
12/06/2000EP1056845A1 Immunological methods to modulate myostatin in vertebrate subjects
12/06/2000EP1056844A1 Human receptor gpr14, and a method of finding agonist and antagonist to human and rat gpr14
12/06/2000EP1056843A1 Therapeutic blockade of icer synthesis to prevent icer-mediated inhibition of immune cell activity